Clinical Trial

Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the effectiveness of prophylactic administration of intra-thecal nicardipine though lumbar cerebrospinal fluid drain in prevention of symptomatic vasospasm in patients with subarachnoid hemorrhage due to rupture of cerebral aneurysms.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-01 -> 2027-03 2026-07-31
minor Completion pushed: 2027-01 -> 2027-03 2026-07-31
Trial Details
NCT Number NCT07246629
Lead Sponsor Wake Forest University Health Sciences
Conditions Subarachnoid Hemorrhage
Enrollment 214 participants
Start Date 2026-09
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-30